## Note
nid: 1505170013301
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_2::Cheesy_Dorian_(M3), #AK_Step2_v11::!Shelf::#Cards_AnKing_Did::6im, #AK_Step2_v11::!Shelf::IM::no_dupes, #AK_Step2_v11::!Shelf::IM::no_dupes::only_step2, #AK_Step2_v11::#OME_banner, #AK_Step2_v11::#Resources_by_rotation::IM::uw::rheum/ortho::rheum/ortho_dorian, #AK_Step2_v11::#Resources_by_rotation::IM::uw::rheum/ortho::rheum/ortho_zanki, #AK_Step2_v11::#Subjects::Immunology_&_Pathology::02_Immunology::Autoimmune_Disorders::Reynaud_Syndrome, #AK_Step2_v11::Original_decks::Dorian::im::uw::rheum/ortho, #AK_Step2_v11::Original_decks::Zanki_Step_2::IM::Rheum/Ortho
markdown: false

### Text
Which form of <u>Raynaud's phenomenon</u>, <i>primary</i> or
<i>secondary</i>, is characterized by <b>asymmetric</b>
<b>attacks</b> with clinical features of <b>tissue ischemia</b>
(e.g. numbness, ulcers)?
<div>
  {{c1::Secondary Raynaud's phenomenon}}
</div>

### Extra
<i>patients should be tested for <b>autoantibodies</b> (e.g.
<b><font color="#FC0280">ANA</font></b>) and inflammatory
markers</i>
<div>
  <div>
    <i><img src="rp.png"></i>
  </div>
</div>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid


### Sketchy


### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href="https://onlinemeded.org?ref=anki"><img src=
  "_OME_AnkiFlashcards_General_4.png"></a>
</div>

### Additional Resources


### One by one

